Delivery Order SPE2DB22D2211-SPE2DB25FSDEW
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,235.58 by the Defense Logistics Agency for 60 tablets of Otezla 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitive award utilized firm fixed pricing with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,324.90. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. The award was not designated as a set-aside contract and was competitively awarded. Performance of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,028.75 firm fixed price delivery order contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a firm fixed price delivery order from the Defense Logistics Agency's Medical Supply Chain for Otezla 30 mg tablets (60-count units) valued at $35,634.81. This non-set-aside, competitively awarded contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The order represents a standard pharmaceutical supply delivery executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,764.93 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of August 20, 2025. This competitive award, issued on August 19, 2025, carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $3,379.69. This competitive award, issued without a set-aside designation, employs firm fixed pricing and calls for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 13, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $60,644.38. The contract carries a firm fixed price structure with an ultimate completion date of August 14, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $31,530.56 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Otezla 30 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 28, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg with a ceiling value of $12,882.51 on August 15, 2025. This competitively awarded, firm fixed-price delivery order is due for completion by August 18, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to meet federal procurement requirements...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDEWDelivery Order
AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Otezla 30 mg tablets (60-count units) valued at $34,867.15. The contract, which is not designated as a set-aside, carries a firm fixed price structure with an ultimate completion date of August 20, 2025. This delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. The pharmaceutical will be sourced from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's established role as a critical federal pharmaceutical distributor within the DLA Medical Supply Chain. The company's competitively awarded contract portfolio demonstrates its capability to fulfill federal procurement requirements across diverse therapeutic areas, including specialty medications, brand-name and generic drugs, and medical devices. The DLA Troop Support Medical IDC enables AmerisourceBergen to serve multiple federal health system customers, including the Defense Health Agency and U.S. Coast Guard, supporting military healthcare programs and operations worldwide through flexible ordering mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.9k | 8/19/25 |